IPO Rush: Ola Electric, Akums Drugs Among 10 Issues To Hit Street This Week, Another 10 To List
India's primary market will see a flurry of activity this week, with market participants awaiting 10 public issues and another 10 listings. Traders will eye the IPOs of Ola Electric Mobility Ltd., Ceigall India Ltd., and Akums Drugs and Pharmaceuticals Ltd. in the main board segment during the week ending Aug. 2.
Bengaluru-based Ola Electric Mobility has priced its initial public offer at Rs 72–76 per share, valuing the company at Rs 33,522 crore. Ola Electric will be raising Rs 5,500 crore in the primary issue and Rs 645.6 crore via an offer-for-sale from promoter entities and other investors.
The initial public offering of Ceigall India will open at a price range of Rs 380–401 per share. The public issue consists of a fresh issue of shares worth Rs 684.5 crore and an offer-for-sale component consisting of 1.41 crore shares.
Akums Drugs and Pharmaceuticals Ltd. has set a price band of Rs 646–679 per share for its issue. The public offering is a combination of a fresh issue of equity shares worth Rs 680 crore and an offer-for-sale of 1.73 crore shares.
Dhariwalcorp Ltd., Utssav Cz Gold Jewels Ltd., Rajputana Industries Ltd., Ashapura Logistics Ltd., Kizi Apparels Ltd., Sathlokhar Synergys E&C Global Ltd., and Bulkcorp International Ltd. will open for subscription under the SME segment.
Meanwhile, this week will see 10 listings, and all of them are in the SME segment. Chetana Education Ltd., Manglam Infra and Engineering Ltd., VL Infraprojects Ltd., VVIP Infratech Ltd., and SAR Televenture Ltd. RNFI Services Ltd. will debut from July 29 to July 31.
In the following three days, shares of SA Tech Software India Ltd., Esprit Stones Ltd., Clinitech Laboratory Ltd., Aprameya Engineering Ltd., Trom Industries Ltd. will debut in the SME space.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets